Scientific Reports · Oct 30, 2026
Normal-weight central obesity and cardiometabolic risk among adolescents and young adults in 70 countries
By Aychiluhm SB, Ross AG, Isaac V et al.
Body mass index (BMI) does not capture central adiposity, which raises cardiometabolic risk even at normal BMI. We estimated the prevalence of central obesity and normal-weight central obesity, and their cardiometabolic associations, among adolescents and young adults (15–29 years) in 70 countries using WHO STEPS data (2010–2023; n = 60,618). Central obesity was defined as a waist-to-height ratio ≥ 0.5, and normal-weight central obesity as central obesity with a normal BMI. Prevalence estimates were pooled using a random-effects meta-analysis; multilevel logistic regression examined associated factors and cardiometabolic associations. Pooled prevalence was 42.1% (95% CI 37.9–46.2) for central obesity and 18.8% (95% CI 16.5–21.0) for normal-weight central obesity, with substantial between-country heterogeneity (I ² = 98.9 and 94.0%, respectively). Compared with normal BMI and no central obesity, normal-weight central obesity was associated with higher odds of hypertension (aOR 1.28, 95% CI 1.15–1.41), diabetes (aOR 1.36, 95% CI 1.08–1.71), and elevated cholesterol (aOR 1.90, 95% CI 1.70–2.13). More than two in five young people had central obesity, including nearly one in five with normal BMI; this phenotype was associated with cardiometabolic risk across income settings. Adding waist-based measures to BMI screening could help identify at-risk young people.